potent and selective Mcl-1 PPI inhibitor
completed Ph. I in AML/MDS (IV weekly)
from NMR fragment screening and SBDD
J. Med. Chem., Nov. 4, 2020
Servier, HU + FR / Vernalis, UK
S64315
Servier selective clinical Mcl-1 protein-protein interaction (PPI) inhibitor